Cargando…
Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor
Adrenocortical carcinoma (ACC) during childhood is a rare malignant tumor that frequently results in glucocorticoid and/or androgen excess. When there are signs of microscopic or macroscopic residual disease, adjuvant therapy is recommended with mitotane, an adrenolytic and cytotoxic drug. In additi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109212/ https://www.ncbi.nlm.nih.gov/pubmed/30159150 http://dx.doi.org/10.1530/EDM-18-0059 |